top of page


FDA clears Endovascular Engineering Hēlo thrombectomy and blood-return systems for pulmonary embolism treatment
The FDA has granted 510(k) clearances for Endovascular Engineering's Hēlo thrombectomy and blood-return systems, advancing an integrated approach to pulmonary embolism treatment.

nuaxia
Oct 142 min read


FDA approves SELUTION SLR sirolimus drug-eluting balloon for coronary in-stent restenosis
The FDA has approved Cordis' SELUTION SLR sirolimus drug-eluting balloon for treatment of coronary in-stent restenosis, making it the first sirolimus drug-eluting balloon available in the United States.

nuaxia
Sep 222 min read
bottom of page